Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul 20;27(2):131-133.
doi: 10.4103/meajo.MEAJO_270_18. eCollection 2020 Apr-Jun.

Central Retinal Vein Prethrombosis Secondary to Retinal Vasculitis: Early Detection and Treatment

Piergiacomo Grassi  1 , Caterina Naclerio  2
Affiliations
Case Reports

Central Retinal Vein Prethrombosis Secondary to Retinal Vasculitis: Early Detection and Treatment

Piergiacomo Grassi et al. Middle East Afr J Ophthalmol. .

Abstract

The aim was to report a case of central retinal vein prethrombosis (CRVP), responsive to systemic steroids. An 18-year-old male presented with right sudden blurred vision and central scotoma for 2 days. Right best-corrected visual acuity (BCVA) measured 6/36, and fundoscopy revealed vascular congestion and blurred disc margins. Fluorescein angiography (FA) showed CRVP secondary to retinal vasculitis. Systemic oral prednisone was started. Six months later, right BCVA was 6/6, FA showed reduced vascular congestion, and retinal vasculitis and residual optic disc hyperfluorescence resolved. CRVP should be considered in young patients with sudden central scotoma. Early systemic steroids might be effective in the treatment of "active" retinal vasculitis.

Keywords: Central retinal vein occlusion; central retinal vein prethrombosis; fluorescein angiography; papillophlebitis; retinal vasculitis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Color fundus retinal photography showing increased congestion of retinal vessels, dilated tortuous retinal veins, few spotty flame-shaped intraretinal hemorrhages, and blurred disc margins in the right eye. (b) Spectral domain-optical coherence tomography horizontal scan at presentation, showing increased macular thickness with moderate level of intraretinal and subretinal fluid. (c) 24-2 visual field test, showing multiple paracentral defects in all the quadrants. (d) Fluorescein angiography showing increased vascular congestion, delayed retinal perfusion and arterovenous filling, perivascular staining, and late disc hyperfluorescence in the right eye
Figure 2
Figure 2
(a) Fluorescein angiography at 3-month follow-up showing reduction of the optic disc hyperfluorescence and marked reduction of vascular congestion in the right eye. (b) Fluorescein angiography at 6-month follow-up showing further mild residual optic disc hyperfluorescence, resolved perivascular staining, and some vascular telangiectasias in the upper retinal quadrants in the right eye. (c) Spectral domain-optical coherence tomography horizontal scan at 6-month follow-up, showing normal central macular thickness, resolution of intraretinal and subretinal fluid, and restoration of normal foveal profile
See this image and copyright information in PMC

References

    1. Pierre-Filho Pde T, Pierre AM, Nascimento MA, Marcondes AM. Central retinal vein prethrombosis as an initial manifestation of protein S deficiency. Sao Paulo Med J. 2004;122:134–5. - PMC - PubMed
    1. Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol. 2009;16:202–18. - PMC - PubMed
    1. Purvin VA. Optic neuropathies for the neurologist. Semin Neurol. 2000;20:97–110. - PubMed
    1. Rosenbaum JT, Ku J, Ali A, Choi D, Suhler EB. Patients with retinal vasculitis rarely suffer from systemic vasculitis. Semin Arthritis Rheum. 2012;41:859–65. - PMC - PubMed
    1. Güngör İ, Konuk GE, Süllü Y, Arıtürk N. Papillophlebitis: Treatment of vision loss due to subretinal fluid with intravitreal ranibizumab. Neuroophthalmology. 2014;38:336–9. - PMC - PubMed

Publication types